The move came as a surprise: In May, an FDA advisory committee voted to recommend approval of the drug for children and adults.
The Food and Drug Administration did not approve an epinephrine nasal spray that would have been the first needle-free alternative to epinephrine autoinjectors, including The agency told drugmaker ARS Pharmaceuticals that it needed to conduct another study on the drug, called Neffy, to support approval, the company The rejection came despite the agency’s advisory committee in May voting to recommend approval of the drug in children and adults.
"We are very surprised by this action," Richard Lowenthal, the CEO of ARS Pharmaceuticals said in the statement.The company said it is going to appeal the FDA's request for additional data.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA issues alert for canned Spam sold at H-E-B, warns product may pose health riskThe product 'may not have been adequately processed to reach commercial sterility,' FDA officials warn.
Read more »
| DayQuil, Covid Vaccine Boosters and FDA ScienceThe industry studies that showed a decongestant was effective turned out to be flawed. Sound familiar?
Read more »
CDC, FDA Warn of Weight Loss Supplements That Might Contain a Hidden, Poisonous IngredientU.S. health agencies are flagging certain weight loss supplements that contain yellow oleander, a plant that can lead to severe gastrointestinal and cardiac issues.
Read more »
FDA advisers to discuss future of ‘artificial womb’ for human infantsIndependent advisers to the US Food and Drug Administration will meet Tuesday and Wednesday to discuss the regulations and ethics of creating an artificial womb to increase the chances that extremely premature babies would survive — and without long-term health problems.
Read more »
Natural Cycles gets FDA clearance to use Apple Watch temperature data for birth controlThe Apple Watch is the second wearable compatible with the digital contraceptive feature.
Read more »
Technique to spare diabetic amputations pioneered at UH receives FDA approvalPioneered by researchers at University Hospitals Harrington Heart and Vascular Institute, LimFlow therapy bypasses blockages in the arteries of the legs that have been irreparably damaged by diabetes.
Read more »